Langerhans cell histiocytosis is a group of conditions featuring Langerhans cell proliferation. While more often described in children, they may occur in adults. Some of the conditions are progressive and have a poor prognosis, while others have a relatively good prognosis. Certain factors can help identify patients with high risk disease.
Conditions included under the heading of Langerhans cell histiocytosis include:
(1) histiocytosis X
(2) eosinophilic granuloma
(3) Letterer-Siwe disease
(4) Hand-Schuller-Christian syndrome
(5) Hashimoto-Pritzker syndrome
(6) self-healing histiocytosis
(7) pure cutaneous histiocytosis
(8) Langerhans cell granulomatosis
(9) Type II histiocytosis
(10) nonlipid reticuloendotheliosis
Risk Factor for Progressive Disease |
Relative Risk |
95% Confidence Interval |
osseous plus mucocutaneous involvement |
40.7 |
3.1 – 534 |
involvement of both osseous and extraosseous sites |
37.3 |
21.2 – 65.5 |
relapse as multisystemic disease after treatment for osseous disease |
37.2 |
4.8 – 288.4 |
bone involvement of >= 3 bone sites |
6.1 |
2.2 – 16.9 |
mucous membrane disease |
5.1 |
2.4 – 11.0 |
hepatosplenomegaly in a patient < 3 years of age at presentation |
4.5 |
0.8 – 26.4 |
pituitary-thalamic involvement in the presence of multisystemic disease |
2.2 |
0.9 – 5.3 |
< 5 years of age at presentation |
2.1 |
0.9 – 4.8 |
>= 3 body systems involved |
1.8 |
0.5 – 4.7 |
from Table 7, page 2287.
Specialty: Hematology Oncology
ICD-10: ,